13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001912226
Total reported value
$76.6M
$76.6M
8 檔
166.6%
According to the latest 13F quarterly dataset, QVIDTVM Management LLC managed an equity portfolio of $76.6M at the end of Q3 2024, spanning 8 distinct U.S. exchange-listed positions.
In Q3 2024, QVIDTVM Management LLC displayed an active expansion posture, initiating 1 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 29.49% | -3.29% | — | |
| 2 | SOLV | Solventum CORP | Stock-Healthcare | 24.27% | -12.35% | +13.48% | |
| 3 | WAB | Wabtec CORP | Stock-Industrials | 13.80% | -0.59% | -4.83% | |
| 4 | RTO | Rentokil Initial Plc-sp Adr | Stock-Other | 13.09% | -0.27% | EXIT | |
| 5 | XRAY | Dentsply Sirona Inc | Stock-Healthcare | 8.69% | -5.23% | +75.77% | |
| 6 | BRCC | Brc Inc-a | Stock-Other | 7.71% | +1.04% | +24.21% | |
| 7 | ZGN | Ermenegildo Zegna N.V. | Stock-Other | 2.04% | +1.02% | — | |
| 8 | ✓ | Stock-Other | 0.92% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SOLV | Solventum CORP | +5.7% | +13.48% | Add |
| 2 | XRAY | Dentsply Sirona Inc | +3.5% | +75.77% | Add |
| 3 | ZGN | Ermenegildo Zegna N.V. | +2% | NEW | New buy |
| 4 | BIO | Bio-rad Laboratories-a | +2% | — | Unchanged |
| 5 | ✓ | +0.4% | — | Unchanged | |
| 6 | WAB | Wabtec CORP | -0.6% | -4.83% | Trim |
| 7 | BRCC | Brc Inc-a | -5% | +24.21% | Add |
| 8 | RTO | Rentokil Initial Plc-sp Adr | -8% | -15.59% | Trim |
According to official SEC Form 13F filings, QVIDTVM Management LLC reported a total U.S. public equity portfolio value of $76.6M across 8 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BIO, SOLV, WAB) accounted for 166.6% of total reported equity market value during Q3 2024.
Top New Position Initiated
ZGN
市值: $2.9M
Top Position Liquidated / Trimmed
RTO
前期市值: $26.4M
During Q3 2024, QVIDTVM Management LLC's top holdings by market value included BIO (29.5%)、SOLV (24.3%)、WAB (13.8%). The largest single position, BIO, represented 29.5% of total portfolio value.
In Q3 2024, QVIDTVM Management LLC made 6 total portfolio adjustments, initiating 1 new buys, adding to 3 positions, trimming 2 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.